Restless legs syndrome (RLS), also called Willis-Ekbom disease, is a neurological condition that causes an urge to move the legs, usually with uncomfortable sensations. It can disrupt sleep, travel and quiet activities. Assessment matters because several other problems can feel similar, and treatment should reflect both the symptoms and the person’s medical circumstances. [1]
Recognizing the pattern of restless legs
The important feature is the pattern, not a particular word for the sensation. People may describe crawling, pulling, itching or aching inside the legs. Symptoms commonly appear while sitting or lying still, become more troublesome in the evening, and ease temporarily with walking or stretching. They can return when movement stops. Their frequency and severity may fluctuate. [1]
Clinical assessment considers an urge to move, worsening at rest, relief during movement, an evening or nighttime pattern, and whether another condition better explains the experience. All of these features matter. A symptom checklist cannot establish the diagnosis or determine which medicine is appropriate. [2]
RLS, nighttime movements and other explanations
Periodic limb movements during sleep are repeated involuntary movements observed while someone is asleep. They can accompany RLS, but they are not the same condition. A partner’s report of kicking does not by itself establish RLS. Its defining urge is experienced while awake. [1]
Leg cramps, positional discomfort, nerve symptoms and medication-related restlessness can require different care. Our akathisia guide explains why inner restlessness after a medication change needs a specific prescribing review. Do not assume that every restless sensation is anxiety or RLS. The clinician should consider competing explanations rather than treating the most familiar label. [2]
Contributors and co-occurring conditions
RLS can run in families. Its biology involves iron regulation and brain signaling, but describing it simply as a shortage of dopamine is misleading. Pregnancy, iron deficiency, kidney disease and some medicines may be relevant. An unclear cause does not mean symptoms are imagined or necessarily caused by a psychological problem. [1]
Tell the clinician about prescribed medicines, nonprescription sleep or allergy products, supplements, alcohol and caffeine. Certain antihistamines, antidepressants, anti-nausea medicines and antipsychotics may aggravate symptoms. A review should balance their benefits and risks; do not stop psychiatric treatment independently. Untreated obstructive sleep apnea also deserves attention. [3]
Preparing for an assessment
Start with primary care if the symptoms interrupt sleep, affect daily life or persist despite simple measures. The consultation usually includes your description, medical and family history, medication review and examination. A neurologist or sleep specialist may help when the diagnosis is uncertain or treatment is difficult. A sleep study is sometimes useful for another suspected sleep disorder; it is not routinely needed to diagnose RLS. [2], [4]
Before the appointment, keep a short record of when symptoms begin, what happens during rest and movement, and how sleep and next-day functioning are affected. Note whether symptoms started after a prescription change. Bring previous test results if available. Ask what each proposed test would clarify. Our sleep apnea, RLS and insomnia assessment guide explains the different diagnostic questions.
Daily measures that may help
Regular, tolerable daytime activity, a consistent sleep routine, gentle stretching, massage or a warm bath may ease discomfort. Avoid exhausting exercise immediately before bed. Review caffeine and alcohol intake and seek support to stop smoking if relevant. These measures are options to try, not a promise that symptoms will disappear. [5]
Choose one or two manageable changes and record their effect. For travel or an evening event, consider whether movement breaks and a comfortable seat would make attendance easier. Explain to a partner that getting up may be a response to discomfort. Practical support should respect your preferences and should not turn sleep into a nightly performance test.
Iron tests and treatment need interpretation
The 2025 American Academy of Sleep Medicine (AASM) guideline recommends ferritin and transferrin saturation testing in clinically significant RLS. Results help guide whether iron treatment is appropriate and which form to consider. Do not start iron solely because your symptoms resemble RLS. [3]
Local guidance differs: the Dutch Farmacotherapeutisch Kompas explicitly contrasts NHG primary-care advice with international recommendations about routine iron investigation. Ask which approach applies to your circumstances and how the result would change care. A blood result is one part of assessment, not a stand-alone diagnosis. [6]
Medication choices and their tradeoffs
Prescription treatment may be considered when symptoms remain significantly disruptive. The AASM recommends gabapentin, gabapentin enacarbil or pregabalin for adults and advises against standard use of several dopamine medicines because of augmentation risk. This is guidance for clinicians, not a ranking that identifies the best treatment for every person. [3]
Regional practice and licensing matter. A March 2026 German DGN/DGSM addendum retains a carefully selected, monitored role for dopamine agonists in Germany, Austria and Switzerland. It also notes that gabapentin and pregabalin treatment for RLS is off-label there. Discuss the rationale, alternatives and review plan with the prescriber. [7]
Gabapentinoids can cause sedation and dizziness. Serious breathing problems are a concern particularly with opioids, other sedating drugs or respiratory risk factors. Tell the prescriber about the complete regimen and ask about driving and other activities requiring alertness. Slow or difficult breathing or inability to wake normally requires emergency help. [8]
Opioids have a limited role in selected difficult cases under specialist supervision; dependence and breathing risks need explicit consideration. Magnesium and benzodiazepines should not be presented as established routine RLS treatments. The German guideline does not recommend them for this purpose. [7]
Recognizing augmentation and other treatment problems
Augmentation is a treatment-related worsening in which symptoms may begin earlier, become more intense or spread beyond their previous distribution. Report this pattern, especially during dopamine-based treatment. Do not repeatedly increase the dose or abruptly stop it yourself; the prescriber needs to plan any change. [7]
Also report new compulsive gambling, spending or sexual behavior, unexpected sleep episodes and troublesome daytime drowsiness. Dopamine agonists can cause impulse-control problems and other important adverse effects. With your consent, someone close to you may help identify changes that are difficult to recognize alone. [4]
Pregnancy, childhood and ongoing support
Pregnancy requires a separate benefit-risk assessment for any medicine or supplement. Symptoms can improve after delivery, but do not dismiss severe sleep disruption while pregnant. Children need age-appropriate assessment rather than an adult treatment plan or an assumption that all leg discomfort is growing pains. [1], [3]
Agree on a follow-up date and a practical goal, such as more comfortable evenings or improved daytime functioning. Ask who will review investigations, adjust treatment and respond if symptoms change. Persistent distress and mood difficulties deserve support alongside the neurological assessment. Treatment can help manage RLS, although a permanent cure is not currently established. [5]


